Overview
Marit Inngjerdingen practices in Oslo, Norway. Ms. Inngjerdingen is highly rated in 2 conditions, according to our data. Her top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Leukemia, and Acute Myeloid Leukemia (AML).
Her clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marit Inngjerdingen
Is Marit Inngjerdingen a top-rated expert for Chronic Graft Versus Host Disease (cGvHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Marit Inngjerdingen is classified as an Advanced expert for Chronic Graft Versus Host Disease (cGvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marit Inngjerdingen participate in research or clinical trials?
Yes. Marit Inngjerdingen has published 38 articles and abstracts on conditions like Chronic Graft Versus Host Disease (cGvHD). You can view a list of Marit Inngjerdingen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Graft Versus Host Disease (cGvHD)Ms. Inngjerdingen isAdvanced. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Graft Versus Host Disease (GvHD)Ms. Inngjerdingen isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Inngjerdingen isExperienced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMs. Inngjerdingen isExperienced. Learn about Leukemia.